The House of Lords Science and Technology Committee recently published a report on regenerative medicine in the UK, in which it identified the potential contribution of regenerative medicine to the quality of people's lives and its future importance to the UK economy.
The Committee found that a complex regulatory system and inappropriate funding models may hinder the successful translation of regenerative medicine and cause the UK to miss out on many of the potential health and economic benefits. The report makes recommendations to overcome these barriers and take advantage of the UK's opportunity to become a world leader in regenerative medicine. The Committee proposes that by following these recommendations, the UK can make the most of its strengths which include a world-class science base and many commercial and clinical experts.
Neotherix is cited in the report as an example of the variety of companies working in this field. Also included in the report is a heat map of British regenerative medicine companies which highlights the strength of the regenerative medicine industry in the Yorkshire & Humber region, where Neotherix is based.
Link to the full House of Lords report .
Link to comments on report by Mike Raxworthy (in role as Regener8 Operations Director).